-
Product Insights
Eastern Equine Encephalitis - Drugs In Development, 2024
Empower your strategies with our Eastern Equine Encephalitis – Drugs In Development, 2024 report and make more profitable business decisions. Eastern equine encephalitis (EEE) is an extremely rare but serious and often fatal infection that causes encephalitis or inflammation of the brain. It is spread by the bite of a mosquito infected with EEE virus (EEEV). The spread of EEEV to mammals (including humans and horses) occurs through the bite of infected mosquitoes that feed on both birds and mammals. The...
-
Product Insights
Cytomegalovirus (HHV-5) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Cytomegalovirus (HHV-5) Infections Clinical Trial Report Overview A total of 666 cytomegalovirus (HHV-5) infections clinical trials were conducted as of May 2024. The cytomegalovirus (HHV-5) infections clinical trial report provides a comprehensive understanding of the cytomegalovirus (HHV-5) infections clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions...
-
Product Insights
Pneumococcal Meningitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Pneumococcal Meningitis Clinical Trial Report Overview A total of 53 Pneumococcal Meningitis clinical trials were conducted as of May 2024. The Pneumococcal Meningitis clinical trial report provides a comprehensive understanding of the Pneumococcal Meningitis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·      North America ·      ...
-
Sector Analysis
Genital Herpes Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Genital Herpes Marketed and Pipeline Drugs Report Overview Genital herpes (GH) is a lifelong viral infection of the genitalia and urogenital tract. It is one of the most common sexually transmitted infections (STIs) and is a leading cause of genital ulcers around the world. Key Mechanisms of Action (Marketed) ·      Enzyme Inhibitor ·      Receptor Agonist ·      Genes, Nucleic Acids & Related Components Inhibitor ·      Ion Channel Activator Key Molecule Types ·      Small Molecules ·      Peptide ·      Recombinant Protein ·      Synthetic...
-
Sector Analysis
Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033
Methicillin-Resistant Staphylococcus aureus (MRSA) Report Overview In the 7MM, there were 714,131 hospitalized incident cases of Methicillin-Resistant Staphylococcus aureus (MRSA) in 2023. The hospitalized incident cases of Methicillin-Resistant Staphylococcus aureus (MRSA) will register an AGR of more than 1% during 2023-2033. Methicillin-resistant Staphylococcus aureus (MRSA) is a virulent, antibiotic-resistant bacteria that is associated with considerable morbidity and mortality. MRSA can be categorized according to the setting in which the infection was acquired, as either healthcare-associated MRSA (HA-MRSA), which is acquired...
-
Product Insights
Human Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Product Insights
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Methicillin-Resistant Staphylococcus Aureus (MRSA) Clinical Trial Report Overview A total of 418 MRSA clinical trials were conducted as of January 2024. The MRSA clinical trial report provides a comprehensive understanding of the MRSA clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       Europe ·       ...
-
Product Insights
COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline Market Report Overview Nucleic Acid Amplification Tests (NAAT) involve the amplification of specific nucleic acid sequences of the SARS-CoV-2 virus by targeting specific nucleic acid sequences. NAAT exhibits better sensitivity in comparison to other antigen identification methods. The COVID-19 NAATs pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical...
-
Product Insights
Parasitology and Mycology Rapid Tests and POC Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
Parasitology and Mycology Rapid Tests and POC Pipeline Market Report Overview Parasitology and mycology consist of rapid test kits. These are used for rapid diagnosis, with immediate results, through immunoassays for Plasmodium and Candida albicans. The Parasitology and Mycology Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress,...
-
Sector Analysis
Bacterial Vaginosis (BV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Bacterial Vaginosis (BV) Marketed and Pipeline Drugs Report Overview Bacterial Vaginosis is the most commonly occurring vaginal infection in women of reproductive age. It occurs when the healthy vaginal flora is dominated by BV-associated bacteria (BVAB). The most common BVAB includes Gardnerella vaginalis, Atopobium vaginae, Megasphaera spp., Prevotella spp., and Sneathia spp. BVAB is caused by almost 35 unique bacterial species: a few of them are less frequently detected, including species such as Peptostreptococcus spp., Aerococcus, Anaerococcus, Gemella, and Veillonella...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.